Marmak Multispecility Hospital (Satara) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 30-05-2024
- Paid Up Capital ₹ 90.00 K
as on 30-05-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Marmak Multispecility Hospital (Satara)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 90.00 K , as per Ministry of Corporate Affairs (MCA) records.
Vinod Patil, Bhanudas Sutar, Sanket Shirsath, and Five other members serve as directors at the Company.
- CIN/LLPIN
U85300PN2021PTC202956
- Company No.
202956
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 2021
- Date of AGM
09 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Satara, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Marmak Multispecility Hospital (Satara)?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Patil  | Additional Director | 12-Oct-2021 | Current |
| Bhanudas Sutar | Additional Director | 12-Oct-2021 | Current |
| Sanket Shirsath | Additional Director | 12-Oct-2021 | Current |
| Swapnil Deshmukh | Additional Director | 12-Oct-2021 | Current |
| Nilesh Kuchekar | Director | 27-Jul-2021 | Current |
| Shivraj Gaikwad | Director | 27-Jul-2021 | Current |
Financial Performance of Marmak Multispecility Hospital (Satara).
Marmak Multispecility Hospital (Satara) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Marmak Multispecility Hospital (Satara)?
Unlock access to Marmak Multispecility Hospital (Satara)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Prakruti Diagnostic And Research Centre Private LimitedActive 19 years 11 monthsAnil Pawar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Marmak Multispecility Hospital (Satara)?
Marmak Multispecility Hospital (Satara) has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Marmak Multispecility Hospital (Satara), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marmak Multispecility Hospital (Satara)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
